You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCV GT1

Showing 1 - 25 of 4,833
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic HCV Infection Trial in Clermont-Ferrand (Elbasvir/Grazoprevir Fixed Dose Combination)

Completed
Has Results
  • Chronic HCV Infection
  • Elbasvir/Grazoprevir Fixed Dose Combination
  • Clermont-Ferrand, France
    CHU Clermont-Ferrand
Sep 9, 2020

Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)

Completed
Has Results
  • Hepatitis C Infection
  • (no location specified)
Jan 15, 2021

Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets)

Completed
Has Results
  • Chronic Hepatitis C
  • Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets
  • (no location specified)
Jan 15, 2021

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

Recruiting
  • Chronic Hepatitis C Infection
  • PR4 + LDV/SOF + ASV 4 wk
  • +7 more
  • Beijing, Beijing, China
  • +1 more
Aug 27, 2021

Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

Not yet recruiting
  • Hepatitis C
  • Cirrhosis
  • (no location specified)
Jul 20, 2022

Compensated Cirrhosis Trial in Bangkok (Grazaoprevir/Elbasavir, Grazaoprevir/Elbasavir/RBV)

Unknown status
  • Compensated Cirrhosis
  • Bangkok, Thailand
  • +1 more
Feb 11, 2020

HCV Infection Trial in Hong Kong (SOF+DCV+CDI-31244, SOF+DCV+CDI-31244+ASV)

Withdrawn
  • HCV Infection
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
May 5, 2020

Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
  • Phoenix, Arizona
  • +47 more
Jun 27, 2022

SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients

Recruiting
  • Hepatitis C
  • Epclusa (sofosbuvir and velpatasvir)
  • Guangzhou, Guangdong, China
    Deparment of Infectious Diseases, the Second Affiliated Hospital
Jul 1, 2021

Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A), Placebo to Grazoprevir 100 mg/Elbasvir 50 mg

Completed
Has Results
  • Chronic Hepatitis C
  • Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A)
  • Placebo to Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet
  • (no location specified)
Nov 11, 2019

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

HIV, HCV Infection, Syphilis Infection Trial in St. John's (Choice of STBBI test(s))

Not yet recruiting
  • HIV Infections
  • +2 more
  • Choice of STBBI test(s)
  • St. John's, Newfoundland & Labrador, Canada
    Memorial University of Newfoundland
Sep 6, 2022

Alpha -1- Microglobulin asEarly Biomarker in Renal Extrahepatic

Not yet recruiting
  • Renal Injury
  • HCV
    • (no location specified)
    May 3, 2022

    HIV Trial in United States (N332-GT5 gp140 (IM, Bolus), N332-GT5 gp140 (IM, Fractioned), N332-GT5 gp140 (SC, Bolus))

    Not yet recruiting
    • HIV
    • N332-GT5 gp140 (IM, Bolus)
    • +7 more
    • San Francisco, California
    • +7 more
    Sep 8, 2023

    Hepatitis C Viral Trial in Dundee

    Active, not recruiting
    • Hepatitis C Viral
      • Dundee, United Kingdom
        NHS Tayside
      Nov 14, 2022

      HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

      Completed
      Has Results
      • HCV
      • +2 more
      • (no location specified)
      Jul 28, 2021

      HIV-1-infection Trial in Kigali, Johannesburg (eOD-GT8 60mer mRNA Vaccine (100µg))

      Active, not recruiting
      • HIV-1-infection
      • eOD-GT8 60mer mRNA Vaccine (100µg)
      • Kigali, Rwanda
      • +1 more
      Sep 9, 2022

      Hepatitis C Trial in Toronto (HCV care provided by hospitalist during acute psychiatric admission)

      Recruiting
      • Hepatitis C
      • HCV care provided by hospitalist during acute psychiatric admission
      • Toronto, Ontario, Canada
        Centre for Addiction and Mental Health
      Apr 28, 2022

      Hiv Trial in Amsterdam (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage)

      Not yet recruiting
      • Hiv
      • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage
      • Amsterdam, Netherlands
        The Amsterdam University Medical Centers
      Aug 2, 2023

      Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

      Completed
      Has Results
      • Hepatitis C Virus (HCV)
      • Glecaprevir/pibrentasvir adult formulation
      • Glecaprevir/pibrentasvir pediatric formulation
      • San Francisco, California
      • +37 more
      Sep 19, 2022

      Hepatitis C Infection, HIV Infection Trial in Washington, Bethesda (Nitazoxanide With Pegylated Interferon And Ribavirin)

      Completed
      Has Results
      • Hepatitis C Infection
      • HIV Infection
      • Nitazoxanide With Pegylated Interferon And Ribavirin
      • Washington, District of Columbia
      • +3 more
      Sep 14, 2021

      Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

      Completed
      • Hepatitis C
      • Bradford, United Kingdom
      • +3 more
      Jan 4, 2023

      Hepatitis C Trial in Victoria (Hepatitis C Point of Care Testing and Treatment)

      Recruiting
      • Hepatitis C
      • Hepatitis C Point of Care Testing and Treatment
      • Victoria, British Columbia, Canada
        Cool Aid Community Health Centre
      Jun 6, 2022

      Advanced Solid Tumor Trial in Brussels (GTAEXS617)

      Recruiting
      • Advanced Solid Tumor
      • Brussels, Belgium
        Clinique Universitaires Saint-Luc
      Aug 8, 2023

      HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)

      Recruiting
      • HCV
      • Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
      • Cairo, Egypt
        Faculty of Medicine, Ain-Shams University Research Institute-Cli
      May 2, 2023